US Patent Issued to YEDA RESEARCH AND DEVELOPMENT on Oct. 7 for "Anti-human GRP94 antibodies and uses" (Israeli Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,435,159, issued on Oct. 7, was assigned to YEDA RESEARCH AND DEVELOPMENT Co. LTD. (Rehovot, Israel).

"Anti-human GRP94 antibodies and uses" was invented by Valery Krizhanovsky (Rehovot, Israel) and Yossi Ovadya (Rehovot, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are anti-human Grp94 antibodies. The antibodies may be used to target senescent cells. Thus, the anti-Grp94 antibodies would be useful in treating diseases and conditions associated with cellular senescence. The anti-Grp94 antibodies could target senescent cells in vivo. Therefore, the anti-Grp94 antibodies could be used to target senescent cells associated with age-r...